姜黄素纳米晶注射液的制备及体内外性质评价
Preparation of curcumin nanocrystalline injection and evaluation of its in vivo and in vitro properties
-
摘要: 通过优化姜黄素纳米晶注射液（curcumin nanocrystalline injection）处方及制备工艺，进而提高姜黄素溶出速率及体内生物利用度。采用介质研磨法制备姜黄素纳米晶，以粒径为评价指标，采用Box-Behnken实验设计优化其处方及制备工艺，并对其进行理化性质表征。此外，通过桨法对不同粒径药物溶出进行考察，并研究大鼠体内药代动力学研究。实验结果表明，通过Box-Behnken实验设计得到最优处方和工艺，获得平均粒径为223.1 nm且均一的姜黄素纳米晶。X射线衍射分析和差示扫描量热法测定结果表明，其制备过程中晶型稳定。不同粒径体外溶出实验表明其粒径越小溶出速率越快，溶出程度越高。大鼠体内药代动力学研究显示，姜黄素纳米晶注射液cmax和AUC0-∞分别是姜黄素原料药的4.9和4.1倍。综上，本研究所开发的姜黄素纳米晶注射液，制备工艺稳定，并且能够显著提高药物溶出速率和生物利用度，为姜黄素制剂研究提供了新的思路。
-
关键词:
- 姜黄素 /
- 纳米晶 /
- 工艺优化 /
- Box-Behnken设计 /
- 药代动力学
Abstract: In this study, the formulation and preparation process of curcumin nanocrystalline injection were optimized to improve curcumin dissolution rate and bioavailability in vivo.Media grinding method was used to prepare curcumin nanocrystals, and the particle size was used as the evaluation index.The Box-Behnken experimental design was used to optimize its formulation and preparation process, and to characterize its physical and chemical properties.In addition, the dissolution of nanocrystal with different particle sizes was investigated by the paddle method, and the pharmacokinetics in rats were studied.The experimental results showed that the optimal formula and process were obtained through Box-Behnken experimental design, and that uniform curcumin nanocrystals with an average particle size of 223.1 nm were obtained.The results of X-ray diffraction and differential scanning calorimetry analysis showed that the crystal form was stable during the preparation of nanocrystals. In vitro dissolution experiments with different particle sizes showed that the dissolution rate and the degree of dissolution would increase if the particle size was smaller.Pharmacokinetic studies in rats showed that cmax and AUC0-∞ of curcumin nanocrystal injection were 4.9 and 4.1 times that of curcumin raw materials, respectively.In summary, the curcumin nanocrystal injection developed in this research have a stable preparation process and can significantly improve the dissolution rate and bioavailability of the drug, which provides some ideas for the research on curcumin preparation.-
Keywords:
- curcumin /
- nanocrystalline /
- process optimization /
- Box-Behnken design /
- pharmacokinetics
-
-
[1] . J Intensive Care，2018，6：30. [2] Rong P，Meng JZ，Chen Y. Advance in pathogenesis and strategies of protective and therapeutic in heat stroke［J］. J Biomed Eng Res（生物医学工程研究），2010，29（4）：287-292. [3] Priyadarsini KI. The chemistry of curcumin：from extraction to therapeutic agent［J］. Molecules，2014，19（12）：20091-20112. [4] Odot J，Albert P，Carlier A，et al. In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells［J］. Int J Cancer，2004，111（3）：381-387. [5] Ma N，Li JJ，Song LY，et al. Effects of curcumin pretreatment on the oxidative stress and apoptosis of cardiomyocytes in heatstroke rats in a dry heat environment［J］. Chin J Comp Med（中国比较医学杂志），2018，28（12）：14-18. [6] Xia L，Dong X，Kang Y，et al. Protective effects of curcumin on intestinal mucosa injury of heatstroke rats in the dry heat envrionment of desert and its effects on TLR4/NF-κB signaling pathway［J］. Prog Mod Biomed（现代生物医学进展），2017，17（34）：6648-6652. [7] Ubeyitogullari A，Ciftci ON. A novel and green nanoparticle formation approach to forming low-crystallinity curcumin nanoparticles to improve curcumin''s bioaccessibility［J］. Sci Rep，2019，9（1）：19112. [8] Wang LL，Du J，Zhou YQ，et al. Safety of nanosuspensions in drug delivery［J］. Nanomed-Nanotechnol Biol Med，2017，13（2）：455-469. [9] Bala I，Bhardwaj V，Hariharan S，et al. Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration［J］. J Drug Target，2006，14（1）：27-34. [10] Medarevi? D，Djuri? J，Ibri? S，et al. Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling［J］. Int J Pharm，2018，540（1/2）：150-161. [11] Rabinow BE. Nanosuspensions in drug delivery［J］. Nat Rev Drug Discov，2004，3（9）：785-796. [12] Liu T，Müller RH，M?schwitzer JP. Effect of drug physico-chemical properties on the efficiency of top-down process and characterization of nanosuspension［J］. Expert Opin Drug Deliv，2015，12（11）：1741-1754. [13] Andersson SBE，Alvebratt C，Bergstr?m CAS. Controlled suspensions enable rapid determinations of intrinsic dissolution rate and apparent solubility of poorly water-soluble compounds［J］. Pharm Res，2017，34（9）：1805-1816. [14] Zhang SW，Li XZ，Li WS，et al. Preparation and characterization of curcumin nanosuspensions［J］. Chem Ind For Prod（林产化学与工业），2016，36（2）：109-114. [15] Gigliobianco MR，Casadidio C，Censi R，et al. Nanocrystals of poorly soluble drugs：drug bioavailability and physicochemical stability［J］. Pharmaceutics，2018，10（3）：134. [16] Liu P，Rong XY，Laru J，et al. Nanosuspensions of poorly soluble drugs：preparation and development by wet milling［J］. Int J Pharm，2011，411（1/2）：215-222.
计量
- 文章访问数: 309
- HTML全文浏览量: 11
- PDF下载量: 385
下载:
